APA (7th ed.) Citation

Bedir, Ş., Kapagan, T., Çakan Demirel, B., Tokocin, M., Yıldırım, Ç., Taş, S., . . . Erdem, G. U. (2026). Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors. Journal of Clinical Medicine, 15(5), 1898. https://doi.org/10.3390/jcm15051898

Chicago Style (17th ed.) Citation

Bedir, Şahin, et al. "Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors." Journal of Clinical Medicine 15, no. 5 (2026): 1898. https://doi.org/10.3390/jcm15051898.

MLA (9th ed.) Citation

Bedir, Şahin, et al. "Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors." Journal of Clinical Medicine, vol. 15, no. 5, 2026, p. 1898, https://doi.org/10.3390/jcm15051898.